Stop faking it.
Get WET.
They made a pill for the boys and the whole market went up with it. Nobody built anything for the other half. Palatin Technologies did — they made Vyleesi, and the stock still trades like nobody noticed. $WET is pooled straight against $PTN, so buying the ticker puts you in both.
WET / PTN
warming up…
Every single transfer of $WET, on any venue, leaves 1% behind. It doesn't go to a team wallet — it comes back to holders as $PTN, actual Palatin stock, pro-rata. The more you hold, the more you get. It pools until it's worth sending, then lands in every wallet holding at least $20 of WET at that moment.
Palatin Technologies, Inc. is a real biopharma company in New Jersey, listed on NYSE American under PTN. Their best known product is Vyleesi — bremelanotide — an FDA-approved injection for premenopausal women with hypoactive sexual desire disorder. Translation: a shot in the thigh, forty five minutes before, for women who want to want it.
It's the closest thing to the other side of the little blue pill, and it got roughly none of the attention. One got a household name and two decades of jokes. The other got a ticker nobody talks about.
So that's the trade. $WET is pooled directly against $PTN, the tax pays out in $PTN, and the whole thing points at one underfollowed pharma stock until somebody notices. She's not shy. She's just never been asked.
NYSE American
Two tickers, one buy
WET's main pool is paired straight to $PTN. Buy WET and the trade runs through Palatin stock — you're not choosing between a meme and a biotech, you end up holding the pair.
The 1% comes back
Every transfer leaves 1% behind and it goes back out to holders as $PTN. Trade volume turns into stock in your wallet. You don't claim it, you don't stake it — it just shows up.
Why now
The boys already had their run and everyone piled in late. This one is still early, still small, and pointed at a stock with a market cap most people would call a rounding error. Early is the entire point.